학술논문

Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
Document Type
Article
Source
In: Leukemia. (Leukemia, July 2022, 36(7):1825-1833)
Subject
Language
English
ISSN
14765551
08876924